Navacilla, Daisy Mae C.
HRN: 09-37-59 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/16/2022
CEFUROXIME 500MG (TAB)
05/16/2022
05/23/2022
PO
500mg
Bid
Abrasions
Waiting Final Action
05/16/2022
MUPIROCIN 2%, 15G (TUBE)
05/16/2022
05/23/2022
TOPICAL
1g
Bid
Abrasions
Waiting Final Action